Telehealth companies have become gatekeepers in the obesity drug market. While they provide crucial lifestyle support for patients taking expensive GLP-1 medications, employers are increasingly pressuring them to also limit how much gets spent on the drugs themselves. According to NPR, this creates a tension: these companies profit from helping patients succeed, but their clients—employers and insurers—want them to control costs. It's a reminder that even in healthcare, financial incentives often shape the care people receive.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton